259 related articles for article (PubMed ID: 8597444)
1. Corticotropin releasing hormone in the pathophysiology of melancholic and atypical depression and in the mechanism of action of antidepressant drugs.
Gold PW; Licinio J; Wong ML; Chrousos GP
Ann N Y Acad Sci; 1995 Dec; 771():716-29. PubMed ID: 8597444
[TBL] [Abstract][Full Text] [Related]
2. Corticotropin releasing hormone: relevance to normal physiology and to the pathophysiology and differential diagnosis of hypercortisolism and adrenal insufficiency.
Gold PW; Kling MA; Khan I; Calabrese JR; Kalogeras K; Post RM; Avgerinos PC; Loriaux DL; Chrousos GP
Adv Biochem Psychopharmacol; 1987; 43():183-200. PubMed ID: 3035886
[TBL] [Abstract][Full Text] [Related]
3. [Overlap between atypical depression, seasonal affective disorder and chronic fatigue syndrome].
Juruena MF; Cleare AJ
Braz J Psychiatry; 2007 May; 29 Suppl 1():S19-26. PubMed ID: 17546343
[TBL] [Abstract][Full Text] [Related]
4. Vasopressin and the regulation of hypothalamic-pituitary-adrenal axis function: implications for the pathophysiology of depression.
Scott LV; Dinan TG
Life Sci; 1998; 62(22):1985-98. PubMed ID: 9627097
[TBL] [Abstract][Full Text] [Related]
5. Atypical depression and non-atypical depression: Is HPA axis function a biomarker? A systematic review.
Juruena MF; Bocharova M; Agustini B; Young AH
J Affect Disord; 2018 Jun; 233():45-67. PubMed ID: 29150144
[TBL] [Abstract][Full Text] [Related]
6. Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states.
Gold PW; Chrousos GP
Mol Psychiatry; 2002; 7(3):254-75. PubMed ID: 11920153
[TBL] [Abstract][Full Text] [Related]
7. Corticotropin-releasing hormone in depression and post-traumatic stress disorder.
Kasckow JW; Baker D; Geracioti TD
Peptides; 2001 May; 22(5):845-51. PubMed ID: 11337099
[TBL] [Abstract][Full Text] [Related]
8. Abnormalities in response to vasopressin infusion in chronic fatigue syndrome.
Altemus M; Dale JK; Michelson D; Demitrack MA; Gold PW; Straus SE
Psychoneuroendocrinology; 2001 Feb; 26(2):175-88. PubMed ID: 11087963
[TBL] [Abstract][Full Text] [Related]
9. The organization of the stress system and its dysregulation in depressive illness.
Gold PW
Mol Psychiatry; 2015 Feb; 20(1):32-47. PubMed ID: 25486982
[TBL] [Abstract][Full Text] [Related]
10. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy.
Cleare AJ; Miell J; Heap E; Sookdeo S; Young L; Malhi GS; O'Keane V
J Clin Endocrinol Metab; 2001 Aug; 86(8):3545-54. PubMed ID: 11502777
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: potential clinical implications.
Kling MA; Roy A; Doran AR; Calabrese JR; Rubinow DR; Whitfield HJ; May C; Post RM; Chrousos GP; Gold PW
J Clin Endocrinol Metab; 1991 Feb; 72(2):260-71. PubMed ID: 1846869
[TBL] [Abstract][Full Text] [Related]
12. Psychiatric implications of basic and clinical studies with corticotropin-releasing factor.
Gold PW; Chrousos G; Kellner C; Post R; Roy A; Augerinos P; Schulte H; Oldfield E; Loriaux DL
Am J Psychiatry; 1984 May; 141(5):619-27. PubMed ID: 6324597
[TBL] [Abstract][Full Text] [Related]
13. Anatomy of melancholia: focus on hypothalamic-pituitary-adrenal axis overactivity and the role of vasopressin.
Dinan TG; Scott LV
J Anat; 2005 Sep; 207(3):259-64. PubMed ID: 16185250
[TBL] [Abstract][Full Text] [Related]
14. Hypercortisolemia and depression.
Gillespie CF; Nemeroff CB
Psychosom Med; 2005; 67 Suppl 1():S26-8. PubMed ID: 15953796
[TBL] [Abstract][Full Text] [Related]
15. [The neuroendocrinology of stress and the pathophysiology and therapy of depression and anxiety].
Ströhle A
Nervenarzt; 2003 Mar; 74(3):279-91; quiz 292. PubMed ID: 12627245
[TBL] [Abstract][Full Text] [Related]
16. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress.
Tsigos C; Chrousos GP
J Psychosom Res; 2002 Oct; 53(4):865-71. PubMed ID: 12377295
[TBL] [Abstract][Full Text] [Related]
17. Vasopressin as a target for antidepressant development: an assessment of the available evidence.
Scott LV; Dinan TG
J Affect Disord; 2002 Nov; 72(2):113-24. PubMed ID: 12200202
[TBL] [Abstract][Full Text] [Related]
18. The hypothalamic-pituitary-adrenal axis in anorexia nervosa.
Licinio J; Wong ML; Gold PW
Psychiatry Res; 1996 Apr; 62(1):75-83. PubMed ID: 8739117
[TBL] [Abstract][Full Text] [Related]
19. Chronic imipramine is associated with diminished hypothalamic-pituitary-adrenal axis responsivity in healthy humans.
Michelson D; Galliven E; Hill L; Demitrack M; Chrousos G; Gold P
J Clin Endocrinol Metab; 1997 Aug; 82(8):2601-6. PubMed ID: 9253341
[TBL] [Abstract][Full Text] [Related]
20. The endocrinology of melancholic and atypical depression: relation to neurocircuitry and somatic consequences.
Gold PW; Chrousos GP
Proc Assoc Am Physicians; 1999; 111(1):22-34. PubMed ID: 9893154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
